Note 11 - Related Party Transactions	9 Months Ended
Jun. 29, 2018
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 11—RELATED PARTY TRANSACTIONS On January 17, 2018, Dr. David C. Collins and Mrs. Mary C. Collins first announced, through filing a Schedule 13D Amendment, their determination to reduce their ownership in the Company’s common stock by selling or otherwise disposing of some or all of their shares in the Company and to engage Kerlin Capital Group to assist in a review of their investment in the Company. Subsequently, on June 29, 2018, a Securities Purchase Agreement (the “Purchase Agreement”) was entered into among The David C. Collins 1997 Trust, The Mary C. Collins 1997 Trust, DCMA Holdings, L.P., The Adventures in Learning Foundation, The Collins Family Foundation, The Collins Family Trust, The Collins Charitable Remainder Unitrust No. 97 - 1, Dr. David C. Collins and Mary C. Collins (collectively, the “Collins Parties” which collectively represented the owners of a majority of the outstanding shares of common stock of the Company), the Trust, as the buyer, and the Company for specified sections contained therein. The Purchase Agreement provided for the Trust to purchase the Collins Parties beneficial ownership of 7,495,332 shares of the Company’s common stock, par value $0.0001 (the “Common Stock”), for a purchase price paid by the Trust of $7,495,332 or $1.00 per share (“Sale Transaction”). The Company was made party to the Purchase Agreement for the limited purposes specified in the Purchase Agreement that included providing certain disclosures to and post-transaction director nomination rights for the Trust, as the new majority stockholder of the Company. The Company received no proceeds from the Sale Transaction. In consideration of the Company’s time, expense and effort in connection with the Collins sale process, including the Company’s limited participation in the Purchase Agreement and for fees and expenses in connection with the Purchase Agreement and the Credit Agreement, Dr. and Mrs. Collins entered into an agreement, dated May 10, 2018, as amended on June 29, 2018 ( the “Reimbursement Agreement”), with the Company providing for reimbursement of the Company’s transaction expenses of $402,186. The transaction expenses were paid to the Company at the close of the Sale Transaction. As more fully described in Note 13, the Company entered into a $5.0 million Credit Agreement with the Trust which is also now the owner of a majority of our outstanding shares of stock. The Company’s new Chairman of the Board, Kevin Gruneich, is affiliated with the Trust.

NOTE

11—RELATED

PARTY

TRANSACTIONS

January 17, 2018,

Dr. David C. Collins and Mrs. Mary C. Collins

first

announced, through filing a Schedule

13D

Amendment, their determination to reduce their ownership in the Company’s common stock by selling or otherwise disposing of some or all of their shares in the Company and to engage Kerlin Capital Group to assist in a review of their investment in the Company. Subsequently, on

June 29, 2018,

a Securities Purchase Agreement (the “Purchase Agreement”) was entered into among The David C. Collins

1997

Trust, The Mary C. Collins

1997

Trust, DCMA Holdings, L.P., The Adventures in Learning Foundation, The Collins Family Foundation, The Collins Family Trust, The Collins Charitable Remainder Unitrust

No.

Dr. David C. Collins and Mary C. Collins (collectively, the “Collins Parties” which collectively represented the owners of a majority of the outstanding shares of common stock of the Company), the Trust, as the buyer, and the Company for specified sections contained therein. The Purchase Agreement provided for the Trust to purchase the Collins Parties beneficial ownership of

7,495,332

shares of the Company’s common stock, par value

$0.0001

(the “Common Stock”), for a purchase price paid by the Trust of

$7,495,332

$1.00

per share (“Sale Transaction”). The Company was made party to the Purchase Agreement for the limited purposes specified in the Purchase Agreement that included providing certain disclosures to and post-transaction director nomination rights for the Trust, as the new majority stockholder of the Company. The Company received

proceeds from the Sale Transaction.

In consideration of the Company’s time, expense and effort in connection with the Collins sale process, including the Company’s limited participation in the Purchase Agreement and for fees and expenses in connection with the Purchase Agreement and the Credit Agreement, Dr. and Mrs. Collins entered into an agreement, dated

May 10, 2018,

as amended on

June 29, 2018 (

the “Reimbursement Agreement”), with the Company providing for reimbursement of the Company’s transaction expenses of

$402,186.

The transaction expenses were paid to the Company at the close of the Sale Transaction.

As more fully described in Note

13,

the Company entered into a

$5.0

million Credit Agreement with the Trust which is also now the owner of a majority of our outstanding shares of stock. The Company’s new Chairman of the Board, Kevin Gruneich, is affiliated with the Trust.